Skip to main content
. 2014 Dec 15;5(1):300–308.

Figure 4.

Figure 4

Silencing of WNT2B downregulates cyclin D1 and β-catenin in cisplatin resistant oral cancer cells. (A) GLUT1, cyclin D1 and β-catenin levels in untreated, WNT2B-shRNA or control shRNA transfected CDDP-resistant cells as determined by western blotting with β-actin as the loading control. Quantification of GLUT1 (B), Cyclin D1 (C) and β-catenin (D) protein levels normalized to β-actin, *P < 0.05, **P < 0.01 vs untreated cells.